** Pharmaceuticals group HUTCHMED (China) 0013.HK jumps 10.7% to HK$26.45, highest since March 7
** Stock set for biggest one-day pct rise since March 13, 2024; third-biggest pct gainer on healthcare index .HSCIH, which is up 0.5%
** Co's 2024 net income attributable came in at $37.73 mln vs $100.78 mln in 2023
** Analysts on avg had forecast loss of $58.57 mln
** Jefferies ("buy") says co's FY24 profitability ahead of guidance
** YTD, stock up 16%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。